The deal is Microsoft's second biggest after its $26.2
billion LinkedIn purchase in 2016, and would boost its presence in cloud
services for healthcare.
It has already regulatory approval in the United States and
Australia, and Reuters reported earlier this month it was set to receive EU
approval.
The Commission said its investigation into the deal had
concluded that it would not significantly reduce competition in markets for
transcription software, cloud services, enterprise communication services, PC
operating systems and other products.
"The proposed transaction would raise no competition
concerns on any of the markets examined in the European Economic Area,"
the Commission said.
U.S.-based Nuance serves 77% of U.S. hospitals and helped
launch Apple's Siri virtual assistant.
The Commission said it had examined issues including the
overlap between Microsoft and Nuance's transcription software activities, and
found that they offered "very different products" that, when
combined, would continue to face strong competition from other players.
Tech companies have ramped up acquisitions of AI-focused
firms as more integrate this technology into their products and services.
0 comments:
Post a Comment